Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03384303
Other study ID # 2014-1359
Secondary ID
Status Completed
Phase N/A
First received December 4, 2017
Last updated December 19, 2017
Start date October 1, 2015
Est. completion date May 1, 2016

Study information

Verified date December 2017
Source Rijnstate Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Obesity is an increasing world wide problem. Moreover, the increase in patients who are considered morbidly obese is even higher (Sturm et al, Healt Aff 2004). Conservative approaches such as diets or medication are unsuccessful in the majority of the patients. Additionally, (morbid) obesity leads often to cardiovascular diseases, such as hypertension, dyslipidemia and type 2 diabetes (T2DM). When patients need insulin to regulate their glucose levels, their weight is even more difficult to control. Therefore, bariatric procedures are increasingly performed, with over 8.000 procedures in the Netherlands in 2013. The two most performed types of bariatric surgery in the Netherlands are the Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) and the Laparoscopic Sleeve Gastrectomy (LSG). Within the LRYGB there are different variants available. In a recently initiated randomized controlled trial (RCT) from our centre, a comparison between two variants of RYGB was performed. In this RCT our standard RYGB (s-RYGB:alimentary limb (AL) of 150cm; biliopancreatic limb (BPL) of 75cm) was compared with a RYGB with an long BPL (LBPLRYGB:AL of 75cm and a BPL of 150cm). A LBPLRYGB might improve weight loss and reduction after surgery. The exact mechanism of action is still not fully understood. Stomach volume is decreased and satiety levels often increase, probably due to changes in incretin levels. Passage of foods through the gastrointestinal tract are altered after RYGB. A possible explanation might be found in different levels of incretins (such as GLP-1, PYY and ghrelin) and bile acids (FGF-19 and FGF-21) after bariatric surgery.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date May 1, 2016
Est. primary completion date May 1, 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- General guidelines for bariatric surgery according to Fried (Fried et al, Obes Surg 2007).

- Age > 18 years

- Patients must be able to adhere to the study visit schedule and protocol requirements

- Patients must be able to give informed consent and the consent must be obtained prior to any study procedures

- Patients who are planned for a LRYGB

Exclusion Criteria:

- Binge-eating or associated eating disorder

- Active drug or alcohol addiction

- Pregnancy and when giving breast feeding

- A medical history of bariatric surgery

- Patients with a language barrier which can inhibit patients to follow the correct medical advice

- Any kind of genetic disorder that can inhibit patients to follow the correct medical advice

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Standardized meal test
Preoperatively and postoperatively standardized meal test

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Rijnstate Hospital University College Dublin

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline incretine levels during a standardized meal test four weeks after surgery. Preoperatively and four weeks after surgery
Primary Change from baseline gut hormone levels during a standardized meal test four weeks after surgery. Preoperatively and four weeks after surgery
Primary Change from baseline bile acid levels during a standardized meal test four weeks after surgery. Preoperatively and four weeks after surgery
See also
  Status Clinical Trial Phase
Completed NCT03657927 - A Comparison of McGrath MAC Versus C-MAC Videolaryngoscopes in Morbidly Obese Patients N/A
Recruiting NCT04934826 - Comparison of the Absorption of Hydrolyzed or Intact Proteins in Morbid Obese Patients After the Roux Y Gastric Bypass N/A
Completed NCT03181347 - The Microbiology of Bariatric Surgery N/A
Completed NCT03886870 - Obesity, Lifestyle and Work Intervention N/A
Active, not recruiting NCT04433338 - The PREBA Study: Effect of Preoperative Weight Loss With a 14-day Low-calorie Diet on Surgical Procedure and Outcomes in Patients Undergoing RYGB Surgery N/A
Completed NCT03553849 - Utilization of Very Low Calorie Diet in Obese General Surgery Patients N/A
Completed NCT05854875 - Diabetes Remission After RYGBP and RYGBP With Fundus Resection N/A
Not yet recruiting NCT03203161 - Registry on Obesity Surgery in Adolescents
Not yet recruiting NCT03601273 - Bariatric Embolization Trial for the Obese Nonsurgical Phase 1
Recruiting NCT02129296 - Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study Phase 1/Phase 2
Active, not recruiting NCT01564732 - Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding N/A
Completed NCT02033265 - Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity
Not yet recruiting NCT01652105 - Randomized Trial of Preoperative Diets Before Bariatric Surgery N/A
Completed NCT01963637 - Gastric Volumetry by Gastric Tomodensitometry With Gas N/A
Terminated NCT01759550 - Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
Completed NCT01149512 - Outcomes of the Adjustable Gastric Band in a Publicly Funded Obesity Program N/A
Completed NCT01955993 - Fentanyl Metabolism in Obese Adolescents N/A
Recruiting NCT01685177 - Single Anastomosis Duodeno-Ileal Bypass vs Standard Duodenal Switch as a Second Step After Sleeve Gastrectomy in the Super-Morbid Obese Patient N/A
Completed NCT02929212 - Effect of Number of Meals on Metabolism After Weight Loss Surgery N/A
Completed NCT02414893 - Hunger/Satiety's Physiopathologic Study in Morbidly Obese Patients N/A